Skip to Content

Join the 'Rivaroxaban' group to help and get support from people like you.

Rivaroxaban News

FDA Approves Portola Pharmaceuticals’ Andexxa, First and Only Antidote for the Reversal of Factor Xa Inhibitors

Posted 24 May 2018 by Drugs.com

SOUTH SAN FRANCISCO, Calif., May 03, 2018 (GLOBE NEWSWIRE) – Portola Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo], the first and only antidote indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or ...

Aspirin as Good a Clot Buster as Pricey Drugs After Joint Replacement

Posted 21 Feb 2018 by Drugs.com

WEDNESDAY, Feb. 21, 2018 – Good old aspirin is just as effective as newer, expensive drugs at preventing blood clots after hip or knee replacement, a new clinical trial suggests. Researchers said the findings could change some doctors' prescribing habits. After knee or hip replacement surgery, there's a risk of blood clots in the legs or lungs. So it's routine for patients to take ...

Could a Blood Thinner Actually Raise Stroke Risk for Some?

Posted 16 Feb 2018 by Drugs.com

THURSDAY, Feb. 15, 2018 – Taking blood-thinning drugs is typically thought to ward off stroke in people with the heart rhythm disorder atrial fibrillation. However, new research out of Britain hints – but cannot prove – that the drugs might actually raise the odds of stroke in seniors with a-fib who also have kidney disease. "Chronic kidney disease is common among older people, and one in ...

FDA Approves New 10 mg Dosing for Xarelto (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)

Posted 13 Nov 2017 by Drugs.com

TITUSVILLE, NJ, OCTOBER 30, 2017 – Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) approved the 10 mg once-daily dose of Xarelto (rivaroxaban) for reducing the continued risk for recurrent venous thromboembolism (VTE) after completing at least six months of initial anticoagulation therapy. This approval follows a FDA Priority Review and is based on data f ...

Blood Thinners May Also Protect Brains of A-Fib Patients

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – Blood thinners may pull double duty for people with the heart rhythm disorder atrial fibrillation: New research suggests they help prevent dementia as well as stroke. Because atrial fibrillation increases the risk for stroke, people with the condition are often prescribed blood thinners (also known as anticoagulants) to prevent blood clots that can cause a stroke. ...

Blood Thinners Can Come With Dangerous Side Effects

Posted 3 Oct 2017 by Drugs.com

TUESDAY, Oct. 3, 2017 – Blood-thinning drugs can save your life by preventing a heart attack or stroke caused by artery-blocking blood clots. But these are powerful drugs, and a pair of new studies detail side effects people need to understand before taking them. The effectiveness of a class of blood thinners called nonvitamin K oral anticoagulants (NOACs) can be significantly altered through ...

Undiagnosed Heart Condition 'AFib' May Be Common, Study Suggests

Posted 26 Aug 2017 by Drugs.com

SATURDAY, Aug. 26, 2017 – Many people at risk for atrial fibrillation probably do have the irregular heart rhythm but have not been diagnosed, a new study reports. Nearly 1 out of 3 patients in the study had undetected atrial fibrillation that was caught only through the use of long-term cardiac monitor implants, researchers say. Based on these results, it's likely there's probably a lot more ...

Nurses Learn How to Get Patients to Say 'Yes' to Blood Thinners

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – Online training for nurses increased hospital patients' use of medication that can prevent potentially deadly blood clots, a new study reveals. Nurses sometimes won't give the blood thinning drugs if patients don't want them. So researchers developed the training to teach nurses how to respond when patients say they don't want to take blood thinners. The study included ...

Are Many A-Fib Patients Getting Wrong Doses?

Posted 5 Jun 2017 by Drugs.com

MONDAY, June 5, 2017 – Nearly one in six Americans who takes newer blood thinners for the heart rhythm problem atrial fibrillation may not receive the proper dose, a new study suggests. A-fib is a common condition, marked by an irregular and often rapid heart beat. It's associated with a fivefold increased risk of stroke, but blood thinners reduce that risk. Many a-fib patients also have kidney ...

Better Treatment Might Prevent Hundreds of Thousands of Strokes

Posted 15 May 2017 by Drugs.com

MONDAY, May 15, 2017 – Hundreds of thousands of strokes might be prevented in the United States each year if more people with a heart rhythm disorder called atrial fibrillation took blood-thinning medications, a new study estimates. Atrial fibrillation causes the heart to quiver instead of beating normally. This causes blood to pool and possibly clot, according to the American Heart Association. ...

Blood Thinners May Prevent Dementia in Atrial Fibrillation Patients

Posted 14 May 2017 by Drugs.com

FRIDAY, May 12, 2017 – Blood thinners are often prescribed to prevent strokes in people with the abnormal heart rhythm known as atrial fibrillation. But a new study suggests these drugs may also help keep dementia at bay. The researchers said that the key is to start blood thinners, such as warfarin, soon after atrial fibrillation is diagnosed. That's true even for people at low risk of a stroke ...

Pradaxa Blood Thinner May Beat Warfarin After Bleeding Episode: Study

Posted 2 Dec 2016 by Drugs.com

THURSDAY, Dec. 1, 2016 – Use of a blood thinner is routine for many heart patients, but these drugs come with a risk of episodes of excess bleeding. What, if any, anticoagulant (blood thinner) should these patients take after such episodes arise? A new study suggests that the blood thinner Pradaxa (dabigatran) may be a better choice than the standby drug warfarin in these cases. The reason: ...

Many Atrial Fibrillation Patients Missing Out on Blood Thinners

Posted 16 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 16, 2016 – Half of patients hospitalized with the heart rhythm disorder atrial fibrillation aren't given blood-thinning drugs that reduce the risk of clots and stroke, a new study finds. Atrial fibrillation, a type of irregular heartbeat, puts people at higher risk for blood clots and stroke, researchers from Duke University said. They analyzed nearly 1.6 million admissions for ...

Gene Test May ID Chemo Patients at Risk of Clots: Study

Posted 1 Nov 2016 by Drugs.com

TUESDAY, Nov. 1, 2016 – Genetic testing could help identify breast cancer patients at high risk for the formation of blood clots in their veins, new research suggests. This problem, called venous thromboembolism (VTE), is a serious and potentially fatal complication that can occur during cancer treatment, particularly chemotherapy. Because breast cancer is one of the most common cancers, breast ...

Irregular Heart Rhythm Patients May Not Always Need Blood Thinners: Study

Posted 18 Oct 2016 by Drugs.com

TUESDAY, Oct. 18, 2016 – People with an abnormal heart rhythm called atrial fibrillation typically take powerful blood thinners to prevent strokes. But, some patients who have implanted pacemakers or defibrillators may not always need the drugs, a new study suggests. Those who suffered only short bouts of atrial fibrillation – estimated at 20 seconds or less – were at no more risk for stroke ...

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Atrial Fibrillation, Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Pulmonary Embolism, Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis - Recurrent Event, Prevention of Thromboembolism in Atrial Fibrillation, Pulmonary Embolism - Recurrent Event

Related Drug Support Groups

Xarelto

Rivaroxaban Patient Information at Drugs.com